Search for Clinical Trial Results

Sponsored By

Leukemia, Promyelocytic, Acute - 25 Studies Found

Status Study
Active, not recruiting Study Name: AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Condition: Leukemia, Promyelocytic, Acute
Date: 2005-09-12
Interventions:
  • Drug: all-trans retinoid acid
  • Drug: idarub
Active, not recruiting Study Name: Acute Promyelocytic Leukemia 2006 (APL)
Condition: Leukemia, Promyelocytic, Acute
Date: 2006-09-18
Interventions:
  • Procedure: Arsenic trioxide Ar
Completed Study Name: A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)
Condition: Leukemia, Promyelocytic, Acute
Date: 2007-12-27
Interventions: Drug: Arac Ommit ARAC in the chemotherapy Other Name
Active, not recruiting Study Name: Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database
Condition: Leukemia, Promyelocytic, Acute
Date: 2014-12-03
Completed Study Name: Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
Condition: Acute Promyelocytic Leukemia
Date: 2006-12-05
Interventions:
  • Drug: ATRA 45 mg/m2 day until

Completed Study Name: Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
Condition: Acute Promyelocytic Leukemia
Date: 2007-04-25
Interventions: Drug: AIDA
Completed Study Name: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
Condition: Acute Promyelocytic Leukemia
Date: 2007-07-19
Interventions:
  • Drug: Arsenic Trioxide

Not yet recruiting Study Name: Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
Condition: Acute Promyelocytic Leukemia
Date: 2017-01-24
Interventions: Other: QoL questionnaires
Recruiting Study Name: Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)
Condition: Acute Promyelocytic Leukemia
Date: 2016-09-04
Interventions:
  • Drug: Realgar-Indigo naturalis formula

Recruiting Study Name: Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic
Condition:
  • Relapsed Acute Promyelocytic Leukemia
  • Refractory Acute Date: 2005-09-12
    Interventions:
    • Drug: Arsenic trioxide
    • Drug: Trisenox
Next >>>